BJBMS becomes Biomolecules and Biomedicine

We are excited to annouce the title change of BJBMS from January 2023.
Find out more about this change in our Blog story, Editorial and the Frequently asked questions.

New Impact Factor (2022) for Biomolecules and Biomedicine is 3.4

Read about our new impact factor, performace metrics, and reviewers in a Blog story.

Latest articles

BJBMS continuously publishes highly relevant and trending articles in the Advanced online section.
Check out the list of the most recently published articles here.

Reviews
S1P/S1PR signaling pathway advancements in autoimmune diseases

Ma et al.
Read more

Pharmacology
Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing reactive oxygen species, endoplasmic reticulum stress, and Pannexin-1-mediated ferroptosis

Sun et al.
Read more

New and emerging methods
Validation of Doi’s weighted average glucose as a measure of post-load glucose excursion for clinical use

Badran et al.
Read more

Reviews
Cannabinoids in cancer treatment: Therapeutic potential and legislation

Barbara Daris, Mojca Tancer Verboten, Zeljko Knez, Polonca Ferk
Read more

Photo: Bijambare, Bosnia and Herzegovina

Biomolecules and Biomedicine (formerly the Bosnian Journal of Basic Medical Sciences, BJBMS) is a comprehensive, multidisciplinary open-access medical journal dedicated to the advancement of medical research, practice, and education. The journal publishes pioneering research across the spectrum of pre-clinical studies, translational medicine, and clinical research, thereby advancing our collective knowledge in the realm of health and disease.
Find more information about the scope and aim here...

Edited by: Muzafer Mujic, MD, PhD and Semir Vranic, MD, PhD
Journal Impact Factor® (2022): 3.4
5-year Journal Impact Factor®: 3.6
CiteScore® (2022): 5.3
ISSN: 2831-0896 (Print)
ISSN: 2831-090X (Online)
Open Access
Frequency: Continuously published online. Six printed issues per year.
Published by: The Association of Basic Medical Sciences of FBIH

> Journal indexing and metrics
> Why publish with us?

NEWS, ANNOUNCEMENTS AND HIGHLIGHTS

Announcements

The Reviewer of the Month for March 2024: Eugenia Flores-Alfaro, PhD

10-03-2024

Peer review is an essential part of the scientific publishing process, helping to ensure that research papers meet high standards of quality and accuracy. Each month, the BiomolBiomed Editorial team recognizes a reviewer who has gone above and beyond in providing thoughtful and constructive feedback on the manuscripts they’ve reviewed.

This month, we’re pleased to announce that the Reviewer of the Month Award goes to Eugenia Flores-Alfaro, PhD, a professor-researcher at the Faculty of Chemical-Biological Sciences, Autonomous University of Guerrero, Chilpancingo, Mexico. Dr. Flores-Alfaro’s review stood out for its exceptional quality, providing authors with valuable feedback that helped them improve the clarity and rigor of their research.

We sat down with Dr. Flores-Alfaro to learn more about his approach to peer review and his thoughts on the current state of the publishing industry. Here are a few highlights from our conversation:

Read more about The Reviewer of the Month for March 2024: Eugenia Flores-Alfaro, PhD

Current Issue

Vol. 24 No. 2 (2024)
Published: 11-03-2024

Editorial

Pathology

Molecular Biology

Translational and Clinical Research

View All Issues